» Articles » PMID: 35168587

Posterior Segment Complications of Ahmed Valve Implantation

Overview
Journal BMC Ophthalmol
Publisher Biomed Central
Specialty Ophthalmology
Date 2022 Feb 16
PMID 35168587
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To assess the time, incidence, and outcome of posterior segment complications of Ahmed valve implantation (AVI).

Methods: 248 eyes that underwent AVI were reviewed retrospectively. Visual acuity, preoperative characteristics, and postoperative posterior segment complications were assessed.

Results: The incidence of posterior segment complications of AVI was 31.4% (78/248). The mean follow-up period was 97.4 ± 53.5 months. The mean time to occur posterior segment complication was 1.5 months. The most common posterior segment complication was choroidal detachment (17.7%) and others included ocular decompression retinopathy (3.2%), hypotonic maculopathy (2.8%), vitreous hemorrhage (2.0%), retinal detachment (1.2%), endophthalmitis (1.2%), suprachoroidal hemorrhage (1.2%), epiretinal membrane (0.8%), cystoid macular edema (0.8%), and proliferative vitreoretinopathy (0.4%). Older age, hypertension, and postoperative hypotony had an increased risk of posterior segment complications of AVI.

Conclusions: The overall incidence of posterior segment complications of AVI was 31.4%. Older age, hypertension, and postoperative hypotony were significantly associated with posterior segment complications of AVI.

Citing Articles

Comparison of choroidal detachment with and without hypotony after Ahmed valve implantation.

Jin S, Heo J, Ahn H Jpn J Ophthalmol. 2024; 69(1):110-115.

PMID: 39514040 DOI: 10.1007/s10384-024-01138-3.


Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants.

Holekamp N, Yaqub M, Ranade S, Cantrell R, Singh S, Gazzard G Ophthalmol Ther. 2024; 13(9):2303-2329.

PMID: 39090513 PMC: 11341515. DOI: 10.1007/s40123-024-01001-1.

References
1.
Chu T, Green R . Suprachoroidal hemorrhage. Surv Ophthalmol. 1999; 43(6):471-86. DOI: 10.1016/s0039-6257(99)00037-5. View

2.
Desai M, Gedde S, Feuer W, Shi W, Chen P, Parrish 2nd R . Practice preferences for glaucoma surgery: a survey of the American Glaucoma Society in 2008. Ophthalmic Surg Lasers Imaging. 2011; 42(3):202-8. DOI: 10.3928/15428877-20110224-04. View

3.
Vaziri K, Schwartz S, Kishor K, Fortun J, Moshfeghi D, Moshfeghi A . Incidence of postoperative suprachoroidal hemorrhage after glaucoma filtration surgeries in the United States. Clin Ophthalmol. 2015; 9:579-84. PMC: 4396511. DOI: 10.2147/OPTH.S78359. View

4.
Christakis P, Kalenak J, Tsai J, Zurakowski D, Kammer J, Harasymowycz P . The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes. Ophthalmology. 2016; 123(10):2093-102. DOI: 10.1016/j.ophtha.2016.06.035. View

5.
Sidoti P, Dunphy T, Baerveldt G, Labree L, Minckler D, Lee P . Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology. 1995; 102(7):1107-18. DOI: 10.1016/s0161-6420(95)30904-9. View